2-Methoxyethanol
Star0
Identification
- Generic Name
- 2-Methoxyethanol
- DrugBank Accession Number
- DB02806
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 76.0944
Monoisotopic: 76.0524295 - Chemical Formula
- C3H8O2
- Synonyms
- Not Available
- External IDs
- NSC-1258
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
- Not Available
Interactions
- Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your softwareAbatacept The risk or severity of adverse effects can be increased when Abatacept is combined with 2-Methoxyethanol. Adalimumab The risk or severity of adverse effects can be increased when Adalimumab is combined with 2-Methoxyethanol. Adenovirus type 7 vaccine live The risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with 2-Methoxyethanol. Aldesleukin The risk or severity of adverse effects can be increased when Aldesleukin is combined with 2-Methoxyethanol. Alefacept The risk or severity of adverse effects can be increased when Alefacept is combined with 2-Methoxyethanol. - Food Interactions
- Not Available
Categories
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as dialkyl ethers. These are organic compounds containing the dialkyl ether functional group, with the formula ROR', where R and R' are alkyl groups.
- Kingdom
- Organic compounds
- Super Class
- Organic oxygen compounds
- Class
- Organooxygen compounds
- Sub Class
- Ethers
- Direct Parent
- Dialkyl ethers
- Alternative Parents
- Primary alcohols / Hydrocarbon derivatives
- Substituents
- Alcohol / Aliphatic acyclic compound / Dialkyl ether / Hydrocarbon derivative / Primary alcohol
- Molecular Framework
- Aliphatic acyclic compounds
- External Descriptors
- hydroxyether (CHEBI:46790) / a small molecule (2-METHOXYETHANOL)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- EK1L6XWI56
- CAS number
- 109-86-4
- InChI Key
- XNWFRZJHXBZDAG-UHFFFAOYSA-N
- InChI
- InChI=1S/C3H8O2/c1-5-3-2-4/h4H,2-3H2,1H3
- IUPAC Name
- 2-methoxyethan-1-ol
- SMILES
- COCCO
References
- General References
- Not Available
- External Links
- PubChem Compound
- 8019
- PubChem Substance
- 46505885
- ChemSpider
- 7728
- ChEBI
- 46790
- ChEMBL
- CHEMBL444144
- ZINC
- ZINC000001591817
- PDBe Ligand
- MXE
- Wikipedia
- 2-Methoxyethanol
- PDB Entries
- 1pjx / 2cb8 / 3hbd / 3hbe / 3iwf / 3o4p / 3tew / 3tez / 4zog / 5e63 … show 14 more
Clinical Trials
- Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
Phase Status Purpose Conditions Count
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
Property Value Source melting point (°C) -85.1 °C PhysProp boiling point (°C) 124.1 °C PhysProp water solubility 1E+006 mg/L (at 25 °C) DOW CHEMICAL COMPANY (1981) logP -0.77 HANSCH,C ET AL. (1995) pKa 14.8 (at 25 °C) SERJEANT,EP & DEMPSEY,B (1979) - Predicted Properties
Property Value Source Water Solubility 812.0 mg/mL ALOGPS logP -0.78 ALOGPS logP -0.57 Chemaxon logS 1.03 ALOGPS pKa (Strongest Acidic) 15.12 Chemaxon pKa (Strongest Basic) -2.7 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 2 Chemaxon Hydrogen Donor Count 1 Chemaxon Polar Surface Area 29.46 Å2 Chemaxon Rotatable Bond Count 2 Chemaxon Refractivity 19.3 m3·mol-1 Chemaxon Polarizability 8.22 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule Yes Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption + 0.9834 Blood Brain Barrier + 0.9664 Caco-2 permeable + 0.6774 P-glycoprotein substrate Non-substrate 0.5863 P-glycoprotein inhibitor I Non-inhibitor 0.7864 P-glycoprotein inhibitor II Non-inhibitor 0.8102 Renal organic cation transporter Non-inhibitor 0.8371 CYP450 2C9 substrate Non-substrate 0.7928 CYP450 2D6 substrate Non-substrate 0.8185 CYP450 3A4 substrate Non-substrate 0.7076 CYP450 1A2 substrate Non-inhibitor 0.8685 CYP450 2C9 inhibitor Non-inhibitor 0.9527 CYP450 2D6 inhibitor Non-inhibitor 0.9676 CYP450 2C19 inhibitor Non-inhibitor 0.9149 CYP450 3A4 inhibitor Non-inhibitor 0.9877 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.9894 Ames test Non AMES toxic 0.9132 Carcinogenicity Non-carcinogens 0.6178 Biodegradation Ready biodegradable 0.8722 Rat acute toxicity 1.5125 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.8724 hERG inhibition (predictor II) Non-inhibitor 0.8871
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 104.1377753 predictedDarkChem Lite v0.1.0 [M-H]- 104.2014753 predictedDarkChem Lite v0.1.0 [M-H]- 124.33159 predictedDeepCCS 1.0 (2019) [M+H]+ 104.7031753 predictedDarkChem Lite v0.1.0 [M+H]+ 104.6804753 predictedDarkChem Lite v0.1.0 [M+H]+ 126.67614 predictedDeepCCS 1.0 (2019) [M+Na]+ 104.2010753 predictedDarkChem Lite v0.1.0 [M+Na]+ 104.3125753 predictedDarkChem Lite v0.1.0 [M+Na]+ 134.89355 predictedDeepCCS 1.0 (2019)
Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52